Tech Company Financing Transactions
Revitope Oncology Funding Round
Revitope Oncology, based in Cambridge, raised $8.5 million from private investors.
Transaction Overview
Company Name
Announced On
2/9/2016
Transaction Type
Venture Equity
Amount
$8,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds will be used to continue development of its novel immunotherapy platform for the treatment of solid tumors and hematologic malignancies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
610 Main St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Revitope Oncology, Inc. is a privately-held cancer immunotherapy company developing a novel platform based on redirecting viral immunity for the purpose of developing compounds to treat solid tumors and hematologic malignancies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve Arkinstall
Chief Financial Officer
Mark Clement
Chief Scientific Officer
Werner Meier
Vice President
Patricia Giblin
VP - Human Resources
Lee Marchionna
Browse more venture capital transactions:
Prev: 2/8/2016: Xignite venture capital transaction
Next: 2/9/2016: Boon + Gable venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs